{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:35:22Z","timestamp":1793288122103,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40264-018-0704-9","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T01:56:33Z","timestamp":1535334993000},"page":"1387-1396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Proton Pump Inhibitor Use and Risk of Developing Alzheimer\u2019s Disease or Vascular Dementia: A Case\u2013Control Analysis"],"prefix":"10.1007","volume":"41","author":[{"given":"Patrick","family":"Imfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Jick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"704_CR1","unstructured":"AstraZeneca UK Limited. Losec MUPS tablets 10\/20\u00a0mg [Internet]. SPC (Summary of Product Characteristics. [cited 2016 May 9]. Available from: \n                    https:\/\/www.medicines.org.uk\/emc\/search\n                    \n                  ."},{"key":"704_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/MEG.0b013e3282f52f95","volume":"20","author":"EPM Vliet van","year":"2008","unstructured":"van Vliet EPM, Otten HJ, Rudolphus A, Knoester PD, Hoogsteden HC, Kuipers EJ, et al. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. Eur J Gastroenterol Hepatol. 2008;20:608\u201312.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"704_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1365-2036.2005.02454.x","volume":"21","author":"DA Zink","year":"2005","unstructured":"Zink DA, Pohlman M, Barnes M, Cannon ME. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther. 2005;21:1203\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"704_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","volume":"102","author":"J Leonard","year":"2007","unstructured":"Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007;102:2047\u201356.","journal-title":"Am J Gastroenterol"},{"key":"704_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.7326\/0003-4819-149-6-200809160-00005","volume":"149","author":"M Sarkar","year":"2008","unstructured":"Sarkar M. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149:391\u20138.","journal-title":"Ann Intern Med."},{"key":"704_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176:238\u201346.","journal-title":"JAMA Intern Med."},{"key":"704_CR7","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"Y-X Yang","year":"2006","unstructured":"Yang Y-X, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947\u201353.","journal-title":"JAMA"},{"key":"704_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang Y-X. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the american gastroenterological association. Gastroenterology. 2017;152:706\u201315.","journal-title":"Gastroenterology"},{"issue":"4","key":"704_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","volume":"73","author":"W Gomm","year":"2016","unstructured":"Gomm W, von Holt K, Thom\u00e9 F, Broich K, Maier W, Fink A, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol. 2016;73(4):410\u20136.","journal-title":"JAMA Neurol."},{"key":"704_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00406-014-0554-0","volume":"265","author":"B Haenisch","year":"2015","unstructured":"Haenisch B, von Holt K, Wiese B, Prokein J, Lange C, Ernst A, et al. Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci. 2015;265:419\u201328.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"704_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jgs.15073","volume":"66","author":"SL Gray","year":"2018","unstructured":"Gray SL, Walker RL, Dublin S, Yu O, Aiello Bowles EJ, Anderson ML, et al. Proton pump inhibitor use and dementia risk: prospective population-based study. J Am Geriatr Soc. 2018;66:247\u201353.","journal-title":"J Am Geriatr Soc."},{"issue":"12","key":"704_CR12","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/ajg.2017.196","volume":"112","author":"H Taipale","year":"2017","unstructured":"Taipale H, Tolppanen A-M, Tiihonen M, Tanskanen A, Tiihonen J, Hartikainen S. No Association between proton pump inhibitor use and risk of Alzheimer\u2019s disease. Am J Gastroenterol. 2017;112(12):1802\u20138.","journal-title":"Am J Gastroenterol."},{"key":"704_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40264-018-0638-2","volume":"41","author":"S-K Park","year":"2018","unstructured":"Park S-K, Baek Y-H, Pratt N, Kalisch Ellett L, Shin J-Y. The uncertainty of the association between proton pump inhibitor use and the risk of dementia: prescription sequence symmetry analysis using a Korean healthcare database between 2002 and 2013. Drug Saf. 2018;41:615\u201324 .","journal-title":"Drug Saf."},{"key":"704_CR14","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/jgs.14956","volume":"65","author":"FC Goldstein","year":"2017","unstructured":"Goldstein FC, Steenland K, Zhao L, Wharton W, Levey AI, Hajjar I. Proton pump inhibitors and risk of mild cognitive impairment and dementia. J Am Geriatr Soc. 2017;65:1969\u201374.","journal-title":"J Am Geriatr Soc."},{"key":"704_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0058837","volume":"8","author":"N Badiola","year":"2013","unstructured":"Badiola N, Alcalde V, Pujol A, M\u00fcnter LM, Multhaup G, Lle\u00f3 A, et al. The proton-pump inhibitor lansoprazole enhances amyloid beta production. PLoS One. 2013;8:1\u20138.","journal-title":"PLoS One"},{"key":"704_CR16","doi-asserted-by":"publisher","first-page":"e70487","DOI":"10.1371\/journal.pone.0070487","volume":"8","author":"RK Sodhi","year":"2013","unstructured":"Sodhi RK, Singh N. Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PLoS One. 2013;8:e70487.","journal-title":"PLoS One."},{"key":"704_CR17","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","volume":"118","author":"G Yepuri","year":"2016","unstructured":"Yepuri G, Sukhovershin R, Nazari-Shafti TZ, Petrascheck M, Ghebre YT, Cooke JP. Proton pump inhibitors accelerate endothelial senescence. Circ Res. 2016;118:e36\u201342.","journal-title":"Circ Res"},{"key":"704_CR18","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310:2435\u201342.","journal-title":"JAMA"},{"key":"704_CR19","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1017\/S0007114512004175","volume":"108","author":"F O\u2019Leary","year":"2012","unstructured":"O\u2019Leary F, Allman-Farinelli M, Samman S. Vitamin B12 status, cognitive decline and dementia: a systematic review of prospective cohort studies. Br J Nutr. 2012;108:1948\u201361.","journal-title":"Br J Nutr."},{"key":"704_CR20","unstructured":"Strom BL. Study designs available for pharmacoepidemiology studies. Pharmacoepidemiology. 4th ed. 2007. p. 61\u20139."},{"key":"704_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1192\/bjp.180.3.270","volume":"180","author":"T Stevens","year":"2002","unstructured":"Stevens T, Livingston G, Kitchen G, Manela M, Walker Z, Katona C. Islington study of dementia subtypes in the community. Br J Psychiatry. 2002;180:270\u20136.","journal-title":"Br J Psychiatry"},{"key":"704_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","volume":"23","author":"SS Jick","year":"2003","unstructured":"Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodr\u00edguez LA, Ruig\u00f3mez A, Meier CR, et al. Validity of the general practice research database. Pharmacotherapy. 2003;23:686\u20139.","journal-title":"Pharmacotherapy"},{"key":"704_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2165\/00002018-200427120-00004","volume":"27","author":"L Wood","year":"2004","unstructured":"Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf. 2004;27:871\u201381.","journal-title":"Drug Saf"},{"key":"704_CR24","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60:e128-36.","journal-title":"Br J Gen Pract."},{"key":"704_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336.","journal-title":"Int J Epidemiol."},{"key":"704_CR26","doi-asserted-by":"crossref","unstructured":"Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol. 2001;58:435\u201340.","DOI":"10.1001\/archneur.58.3.435"},{"issue":"4","key":"704_CR27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JAD-2011-110347","volume":"26","author":"Neil M. Davies","year":"2011","unstructured":"Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias. J Alzheimers Dis. 2011;26:699\u2013708.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"9242","key":"704_CR28","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick H, Zornberg G, Jick S, Seshadri S, Drachman D. Statins and the risk of dementia. Lancet. 2000;356:1627\u201331.","journal-title":"The Lancet"},{"issue":"1","key":"704_CR29","doi-asserted-by":"publisher","first-page":"e002080","DOI":"10.1136\/bmjopen-2012-002080","volume":"3","author":"Carlos Martinez","year":"2013","unstructured":"Martinez C, Jones RW, Rietbrock S. Trends in the prevalence of antipsychotic drug use among patients with Alzheimer\u2019s disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open. 2013;3:e002080.","journal-title":"BMJ Open"},{"key":"704_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbi.2016.03.014","volume":"57","author":"Patrick Imfeld","year":"2016","unstructured":"Imfeld P, Toovey S, Jick SS, Meier CR. Influenza infections and risk of Alzheimer\u2019s disease. Brain Behav Immun. 2016;57:187\u201392.","journal-title":"Brain, Behavior, and Immunity"},{"issue":"3","key":"704_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3233\/JAD-121819","volume":"35","author":"Patrick Imfeld","year":"2013","unstructured":"Imfeld P, Brauchli Pernus YB, Jick SS, Meier CR. Epidemiology, co-morbidities, and medication use of patients with Alzheimer\u2019s disease or vascular dementia in the UK. J Alzheimers Dis. 2013;35:565\u201373.","journal-title":"Journal of Alzheimer's Disease"},{"key":"704_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1532-5415.2010.03275.x","volume":"59","author":"SL Gray","year":"2011","unstructured":"Gray SL, Walker R, Dublin S, Haneuse S, Crane PK, Breitner JCS, et al. Histamine-2 receptor antagonist use and incident dementia in an older cohort. J Am Geriatr Soc. 2011;59:251\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"704_CR33","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1532-5415.2007.01270.x","volume":"55","author":"M Boustani","year":"2007","unstructured":"Boustani M, Hall KS, Lane KA, Aljadhey H, Gao S, Unverzagt F, et al. The association between cognition and histamine-2 receptor antagonists in African Americans. J Am Geriatr Soc. 2007;55:1248\u201353.","journal-title":"J Am Geriatr Soc"},{"key":"704_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/archneurol.2008.582","volume":"66","author":"AL Fitzpatrick","year":"2009","unstructured":"Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O\u2019Meara ES, Longstreth WT, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336\u201342.","journal-title":"Arch Neurol."},{"key":"704_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archinternmed.2010.393","volume":"171","author":"M Rusanen","year":"2011","unstructured":"Rusanen M, Kivipelto M, Quesenberry CP, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med. 2011;171:333\u20139.","journal-title":"Arch Intern Med."},{"key":"704_CR36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1017\/S1041610215002082","volume":"28","author":"A Booker","year":"2016","unstructured":"Booker A, Jacob LE, Rapp M, Bohlken J, Kostev K. Risk factors for dementia diagnosis in German primary care practices. Int Psychogeriatr. 2016;28:1059\u201365.","journal-title":"Int Psychogeriatr."},{"key":"704_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0002-9343(80)90363-0","volume":"68","author":"RI Horwitz","year":"1980","unstructured":"Horwitz RI, Feinstein AR. The problem of \u201cprotopathic bias\u201d in case-control studies. Am J Med. 1980;68:255\u20138.","journal-title":"Am J Med"},{"key":"704_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf Rev. 2017;8:273\u201397.","journal-title":"Ther Adv Drug Saf Rev."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-018-0704-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0704-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0704-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T23:09:51Z","timestamp":1566860991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-018-0704-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1007\/s40264-018-0704-9","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]},"assertion":[{"value":"27 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study did not receive any funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Patrick Imfeld, Michael Bodmer, Susan S. Jick, and Christoph R. Meier have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}